Physical Health clinical trials

Explore recruiting physical health clinical trials.

Recruiting physical health studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Physical Health trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

RECLAIM: an Adaptive Platform Trial for the Evaluation of Treatments for Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Pilot / Phase 2 Clinical Trial of GSL-01-001 Administered Orally for 12 Weeks Preceded by a 2 Week Screening Period in Patients Presenting with Symptoms Associated with Irritable Bowel Syndrome with code GSL-01-001

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and safety of 24 weeks sustained-release dexamphetamine in patients with moderate to severe cocaine use disorder with comorbid opioid use disorder - a multicenter randomized, double-blind, placebo-controlled study

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

ATLAS-OLE: An Open-label, Long-term Safety and Efficacy Study of Fitusiran in Patients with Hemophilia A or B, with or without Inhibitory Antibodies to Factor VIII or IX

Ireland, Denmark, Italy, France, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

Physical Health trials by city

Physical Health in Toronto Physical Health in Vancouver Physical Health in Montreal Physical Health in Calgary Physical Health in Edmonton Physical Health in Ottawa Physical Health in Winnipeg Physical Health in Quebec City Physical Health in Hamilton Physical Health in Kitchener Physical Health in London Physical Health in Halifax Physical Health in New York Physical Health in Los Angeles Physical Health in Chicago Physical Health in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease